UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design

The American heart journal, 2008-04, Vol.155 (4), p.609-614

2008

Volltextzugriff (PDF)

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

The New England journal of medicine, 2010-12, Vol.363 (24), p.2310-2319

2010

Volltextzugriff (PDF)

End-of-life preferences of elderly patients with chronic heart failure

European heart journal, 2012-03, Vol.33 (6), p.752-759

2012

Volltextzugriff (PDF)

Noninvasive Evaluation of Pulmonary Capillary Wedge Pressure by BP Response to the Valsalva Maneuver

Chest, 2002-07, Vol.122 (1), p.140-145

2002

Volltextzugriff (PDF)

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

Journal of cardiac failure, 2005-02, Vol.11 (1), p.12-20

2005

Volltextzugriff (PDF)

Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease

Transplantation, 1998-02, Vol.65 (4), p.538-543

1998

Volltextzugriff (PDF)

Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans

Cardiovascular drugs and therapy, 1997, Vol.10 (6), p.717-725

1997

Volltextzugriff (PDF)

Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure

European journal of heart failure, 2001-08, Vol.3 (4), p.457-461

2001

Volltextzugriff (PDF)

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Europace (London, England), 2013-01, Vol.15 (1), p.71-76

2013

Volltextzugriff (PDF)

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study

European journal of heart failure, 2012-11, Vol.14 (11), p.1218-1229

2012

Volltextzugriff (PDF)

Is Blood Pressure Response to the Valsalva Maneuver Related to Neurohormones, Exercise Capacity, and Clinical Findings in Heart Failure?

Chest, 1999-10, Vol.116 (4), p.861-867

1999

Volltextzugriff (PDF)

B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction

European journal of heart failure, 2005-12, Vol.7 (7), p.1164-1167

2005

Volltextzugriff (PDF)

Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study

European heart journal, 2007-09, Vol.28 (17), p.2110-2117

2007

Volltextzugriff (PDF)

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure

Circulation (New York, N.Y.), 1998-11, Vol.98 (21), p.2262-2268

1998

Volltextzugriff (PDF)

Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events

The Journal of pharmacology and experimental therapeutics, 1999-04, Vol.289 (1), p.565

1999

Volltextzugriff (PDF)

Gender‐Related Safety and Efficacy of Cardiac Resynchronization Therapy

Clinical cardiology (Mahwah, N.J.), 2013-11, Vol.36 (11), p.683-690

2013

Volltextzugriff (PDF)

Cryopreserved arterial allografts in the treatment of major vascular infection: A comparison with conventional surgical techniques

The Journal of thoracic and cardiovascular surgery, 1998-12, Vol.116 (6), p.965-972

1998

Volltextzugriff (PDF)

Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo : blunted response in essential hypertension

Circulation (New York, N.Y.), 1990-06, Vol.81 (6), p.1762-1767

1990

Volltextzugriff (PDF)

One-year outcome after CRT implantation in NYHA class IV in comparison to NYHA class III patients

Clinical research in cardiology, 2013-07, Vol.102 (7), p.505-511

2013

Volltextzugriff (PDF)

The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure

The American heart journal, 2001-08, Vol.142 (2), p.340-349

2001

Volltextzugriff (PDF)

Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial

The American heart journal, 2008-09, Vol.156 (3), p.520-526

2008

Volltextzugriff (PDF)

Relationship between pre-implant ejection fraction and outcome after cardiac resynchronization therapy in symptomatic patients

Acta Cardiologica, 2014-08, Vol.69 (4), p.424-432

2014

Volltextzugriff (PDF)

Effects of Cilazapril on Vascular Structure and Function in Essential Hypertension

Hypertension (Dallas, Tex. 1979), 1996-03, Vol.27 (3), p.371-376

1996

Volltextzugriff (PDF)

Assessment of the extent of jeopardized myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrile imaging

The American heart journal, 1991-07, Vol.122 (1), p.7-12

1991

Volltextzugriff (PDF)

Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation

Transplantation, 2000-03, Vol.69 (5), p.847

2000

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: Study protocol and design

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

End-of-life preferences of elderly patients with chronic heart failure

Noninvasive Evaluation of Pulmonary Capillary Wedge Pressure by BP Response to the Valsalva Maneuver

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease

Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans

Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study

Is Blood Pressure Response to the Valsalva Maneuver Related to Neurohormones, Exercise Capacity, and Clinical Findings in Heart Failure?

B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction

Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure

Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events

Gender‐Related Safety and Efficacy of Cardiac Resynchronization Therapy

Cryopreserved arterial allografts in the treatment of major vascular infection: A comparison with conventional surgical techniques

Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo : blunted response in essential hypertension

One-year outcome after CRT implantation in NYHA class IV in comparison to NYHA class III patients

The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure

Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial

Relationship between pre-implant ejection fraction and outcome after cardiac resynchronization therapy in symptomatic patients

Effects of Cilazapril on Vascular Structure and Function in Essential Hypertension

Assessment of the extent of jeopardized myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrile imaging

Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation

Aktive Filter

Suchergebnisse filtern